Significance of postoperative adjuvant immunochemotherapy after curative resection of colorectal cancers: Identification of responders incorporating the age factor

  • Authors:
    • Yoshinori Munemoto
    • Yoshiro Iida
    • Kou Ohata
    • Hideo Saito
    • Katsunori Fujisawa
    • Yoshiro Kasahara
    • Tsuyoshi Mitsui
    • Yasuyuki Asada
    • Shoji Miura
  • View Affiliations

  • Published online on: March 1, 2004     https://doi.org/10.3892/or.11.3.623
  • Pages: 623-635
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

To identify responders when protein-bound polysaccharide (PSK) is used in adjuvant immunochemotherapy after curative resection of colorectal cancers, we examined the host and tumor factors that affect the prognosis incorporating the age factor. A total of 101 patients who had undergone macroscopic curative resection of colorectal cancer were treated with mitomycin C + fluoropyrimidine oral antineoplastics + PSK (MFP therapy) for two years in principle. These cases were divided into two age groups of <65 years [n=55; 54.8±8.3 years (mean ± SD)] and ≥65 years (n=46; 69.1±3.3 years). Host factors including humoral factors (complement C3 and C4), immunosuppressive acidic protein (IAP), lymphocyte transformation (cellular factors) induced by various mitogens [phytohemagglutinin (PHA), pokeweed mitogen (PWM), and PSK], and tumor markers (CEA, CA19-9) were measured. The cases were divided by the cut-off value of each parameter into ≥ cut-off value and < cut-off value groups, and the 5-year survival rates were compared. The cut-off values obtained for these parameters and the tumor factor (Dukes class) were subjected to multivariate analysis to identify the markers that affect prognosis. The 5-year mortality rate was 74.5% in the <65 age group and 56.8% in the ≥65 age group, with a tendency of better prognosis in the <65 age group (p=0.1109). Compared to the <65 age group, the ≥65 age group showed higher levels of C3 (2-way ANOVA: p=0.0582), C4 (p=0.0009) and IAP (p=0.0110) over time, but lower PSK-induced stimulation index (SI) as an indicator of cellular immunity) (p=0.0001) and PHA-induced SI (p=0.2650) over time. These results indicated that compared to patients aged <65 years, patients aged ≥65 years were characterized by lowered cellular immunity in addition to augmented complement production and an aggravated immunosuppressive state, suggesting the presence of some differences in host immune function with aging. Using the Cox proportional hazard model, the prognostic determinant was found to be Dukes C in the <65 age group, and CEA level in the ≥65 age group. The present results suggested that analysis of prognostic determinants of this therapy should take into account the age factor. Especially in elderly subjects, responders to PSK may be identified using the preoperative CEA value.

Related Articles

Journal Cover

March 2004
Volume 11 Issue 3

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Munemoto Y, Iida Y, Ohata K, Saito H, Fujisawa K, Kasahara Y, Mitsui T, Asada Y and Miura S: Significance of postoperative adjuvant immunochemotherapy after curative resection of colorectal cancers: Identification of responders incorporating the age factor. Oncol Rep 11: 623-635, 2004.
APA
Munemoto, Y., Iida, Y., Ohata, K., Saito, H., Fujisawa, K., Kasahara, Y. ... Miura, S. (2004). Significance of postoperative adjuvant immunochemotherapy after curative resection of colorectal cancers: Identification of responders incorporating the age factor. Oncology Reports, 11, 623-635. https://doi.org/10.3892/or.11.3.623
MLA
Munemoto, Y., Iida, Y., Ohata, K., Saito, H., Fujisawa, K., Kasahara, Y., Mitsui, T., Asada, Y., Miura, S."Significance of postoperative adjuvant immunochemotherapy after curative resection of colorectal cancers: Identification of responders incorporating the age factor". Oncology Reports 11.3 (2004): 623-635.
Chicago
Munemoto, Y., Iida, Y., Ohata, K., Saito, H., Fujisawa, K., Kasahara, Y., Mitsui, T., Asada, Y., Miura, S."Significance of postoperative adjuvant immunochemotherapy after curative resection of colorectal cancers: Identification of responders incorporating the age factor". Oncology Reports 11, no. 3 (2004): 623-635. https://doi.org/10.3892/or.11.3.623